"gp100 Melanoma Antigen" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A melanosome-associated protein that plays a role in the maturation of the MELANOSOME.
| Descriptor ID |
D058951
|
| MeSH Number(s) |
D12.776.543.306 D12.776.624.301.500 D23.050.285.439.500
|
| Concept/Terms |
gp100 Melanoma Antigen- gp100 Melanoma Antigen
- Antigen, gp100 Melanoma
- Melanoma Antigen, gp100
- gp100 Melanoma-Associated Antigen
- Antigen, gp100 Melanoma-Associated
- Melanoma-Associated Antigen, gp100
- gp100 Melanoma Associated Antigen
- ME20 Antigen
- Melanocyte Lineage-Specific Antigen gp100
- Melanocyte Lineage Specific Antigen gp100
- Melanocyte Protein Pmel 17
- Silver Locus Protein Homolog
- Melanoma-Associated Antigen gp100
- Melanoma Associated Antigen gp100
- Melanoma-Associated ME20 Antigen
- Antigen, Melanoma-Associated ME20
- ME20 Antigen, Melanoma-Associated
- Melanoma Associated ME20 Antigen
- MLSA gp100
- Pmel17 Melanoma Antigen
- Melanoma Antigen, Pmel17
- gp100 Melanocyte Differentiation Antigen
- Melanoma Antigen Glycoprotein 100
|
Below are MeSH descriptors whose meaning is more general than "gp100 Melanoma Antigen".
Below are MeSH descriptors whose meaning is more specific than "gp100 Melanoma Antigen".
This graph shows the total number of publications written about "gp100 Melanoma Antigen" by people in this website by year, and whether "gp100 Melanoma Antigen" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2008 | 0 | 1 | 1 |
| 2012 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "gp100 Melanoma Antigen" by people in Profiles.
-
Three Types of Nodal Melanocytic Nevi in Sentinel Lymph Nodes of Patients With Melanoma: Pitfalls, Immunohistochemistry, and a Review of the Literature. Am J Dermatopathol. 2020 Oct; 42(10):739-744.
-
Epithelioid angiomyolipoma mimicking metastatic melanoma in a liver tumor. J Cutan Pathol. 2020 Sep; 47(9):824-828.
-
Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy. J Clin Invest. 2018 04 02; 128(4):1338-1354.
-
SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity. Cancer Immunol Res. 2017 08; 5(8):618-629.
-
CpG-based immunotherapy impairs antitumor activity of BRAF inhibitors in a B-cell-dependent manner. Oncogene. 2017 07 13; 36(28):4081-4086.
-
Vaginal lentigo in a postmenopausal patient: Report of a unique entity. J Obstet Gynaecol. 2017 Apr; 37(3):400-402.
-
Proliferation indices correlate with diagnosis and metastasis in diagnostically challenging melanocytic tumors. Hum Pathol. 2016 07; 53:73-81.
-
Retroperitoneal PEComa related to the femoral nerve. J Neurosurg Sci. 2017 02; 61(1):109-112.
-
A multi-trimeric fusion of CD40L and gp100 tumor antigen activates dendritic cells and enhances survival in a B16-F10 melanoma DNA vaccine model. Vaccine. 2015 Sep 11; 33(38):4798-806.
-
Atypical histopathologic features in a melanocytic nevus after cryotherapy and pregnancy. J Cutan Pathol. 2014 Oct; 41(10):802-5.